世界の眼炎症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Ocular Inflammation Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4225 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、眼炎症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、モノクローナル抗体、コルチコステロイド、毛様体筋麻痺薬、抗生物質、鎮痛剤、抗ウイルス剤、抗真菌剤）、用途別市場規模（小売薬局、病院薬局、オンライン薬局、ドラッグストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・眼炎症治療の市場動向 ・企業の競争状況、市場シェア ・眼炎症治療の種類別市場規模（免疫抑制剤、モノクローナル抗体、コルチコステロイド、毛様体筋麻痺薬、抗生物質、鎮痛剤、抗ウイルス剤、抗真菌剤） ・眼炎症治療の用途別市場規模（小売薬局、病院薬局、オンライン薬局、ドラッグストア） ・眼炎症治療の北米市場規模2016-2027（アメリカ、カナダ） ・眼炎症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・眼炎症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・眼炎症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・眼炎症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan Plc.、Cipla Ltd.、Pfizer, Inc.、Novartis AG、Valeant Pharmaceuticals International, Inc.、Alimera Sciences, Inc.、Akorn, Inc.、Abbvie, Inc.、Eyegate Pharmaceuticals, Inc.、pSivida Corporation） ・結論

Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines. Patients are exhibiting a particular preference to the type of ocular inflammation treatment being adopted, considering the range of treatment options, their comparative effectiveness, and convenience in terms of mode of administration.
The global market for ocular inflammation treatment is expected to grow sharply in the coming years. Prominent market players are diversifying their product lines to cater treatment of all forms of uveitis occurring worldwide.

Market Analysis and Insights: Global Ocular Inflammation Treatment Market
The global Ocular Inflammation Treatment market size is projected to reach US$ 29620 million by 2026, from US$ 20230 million in 2019, at a CAGR of 5.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ocular Inflammation Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ocular Inflammation Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ocular Inflammation Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ocular Inflammation Treatment market.

Global Ocular Inflammation Treatment Scope and Market Size
Ocular Inflammation Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ocular Inflammation Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunosuppressant
Monoclonal Antibodies
Corticosteroids
Cycloplegic Agents
Antibiotics
Analgesics
Antivirals
Antifungal

Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Drug Stores

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan Plc.
Cipla Ltd.
Pfizer, Inc.
Novartis AG
Valeant Pharmaceuticals International, Inc.
Alimera Sciences, Inc.
Akorn, Inc.
Abbvie, Inc.
Eyegate Pharmaceuticals, Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ocular Inflammation Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunosuppressant
1.2.3 Monoclonal Antibodies
1.2.4 Corticosteroids
1.2.5 Cycloplegic Agents
1.2.6 Antibiotics
1.2.7 Analgesics
1.2.8 Antivirals
1.2.9 Antifungal
1.3 Market by Application
1.3.1 Global Ocular Inflammation Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.3.5 Drug Stores
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Ocular Inflammation Treatment Market Perspective (2016-2027)
2.2 Ocular Inflammation Treatment Growth Trends by Regions
2.2.1 Ocular Inflammation Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ocular Inflammation Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Ocular Inflammation Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Ocular Inflammation Treatment Industry Dynamic
2.3.1 Ocular Inflammation Treatment Market Trends
2.3.2 Ocular Inflammation Treatment Market Drivers
2.3.3 Ocular Inflammation Treatment Market Challenges
2.3.4 Ocular Inflammation Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Ocular Inflammation Treatment Players by Revenue
3.1.1 Global Top Ocular Inflammation Treatment Players by Revenue (2016-2021)
3.1.2 Global Ocular Inflammation Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Ocular Inflammation Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ocular Inflammation Treatment Revenue
3.4 Global Ocular Inflammation Treatment Market Concentration Ratio
3.4.1 Global Ocular Inflammation Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ocular Inflammation Treatment Revenue in 2020
3.5 Ocular Inflammation Treatment Key Players Head office and Area Served
3.6 Key Players Ocular Inflammation Treatment Product Solution and Service
3.7 Date of Enter into Ocular Inflammation Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Ocular Inflammation Treatment Breakdown Data by Type
4.1 Global Ocular Inflammation Treatment Historic Market Size by Type (2016-2021)
4.2 Global Ocular Inflammation Treatment Forecasted Market Size by Type (2022-2027)

5 Ocular Inflammation Treatment Breakdown Data by Application
5.1 Global Ocular Inflammation Treatment Historic Market Size by Application (2016-2021)
5.2 Global Ocular Inflammation Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Ocular Inflammation Treatment Market Size (2016-2027)
6.2 North America Ocular Inflammation Treatment Market Size by Type
6.2.1 North America Ocular Inflammation Treatment Market Size by Type (2016-2021)
6.2.2 North America Ocular Inflammation Treatment Market Size by Type (2022-2027)
6.2.3 North America Ocular Inflammation Treatment Market Size by Type (2016-2027)
6.3 North America Ocular Inflammation Treatment Market Size by Application
6.3.1 North America Ocular Inflammation Treatment Market Size by Application (2016-2021)
6.3.2 North America Ocular Inflammation Treatment Market Size by Application (2022-2027)
6.3.3 North America Ocular Inflammation Treatment Market Size by Application (2016-2027)
6.4 North America Ocular Inflammation Treatment Market Size by Country
6.4.1 North America Ocular Inflammation Treatment Market Size by Country (2016-2021)
6.4.2 North America Ocular Inflammation Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Ocular Inflammation Treatment Market Size (2016-2027)
7.2 Europe Ocular Inflammation Treatment Market Size by Type
7.2.1 Europe Ocular Inflammation Treatment Market Size by Type (2016-2021)
7.2.2 Europe Ocular Inflammation Treatment Market Size by Type (2022-2027)
7.2.3 Europe Ocular Inflammation Treatment Market Size by Type (2016-2027)
7.3 Europe Ocular Inflammation Treatment Market Size by Application
7.3.1 Europe Ocular Inflammation Treatment Market Size by Application (2016-2021)
7.3.2 Europe Ocular Inflammation Treatment Market Size by Application (2022-2027)
7.3.3 Europe Ocular Inflammation Treatment Market Size by Application (2016-2027)
7.4 Europe Ocular Inflammation Treatment Market Size by Country
7.4.1 Europe Ocular Inflammation Treatment Market Size by Country (2016-2021)
7.4.2 Europe Ocular Inflammation Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Ocular Inflammation Treatment Market Size (2016-2027)
8.2 Asia-Pacific Ocular Inflammation Treatment Market Size by Type
8.2.1 Asia-Pacific Ocular Inflammation Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ocular Inflammation Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ocular Inflammation Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Ocular Inflammation Treatment Market Size by Application
8.3.1 Asia-Pacific Ocular Inflammation Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ocular Inflammation Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ocular Inflammation Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Ocular Inflammation Treatment Market Size by Region
8.4.1 Asia-Pacific Ocular Inflammation Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ocular Inflammation Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Ocular Inflammation Treatment Market Size (2016-2027)
9.2 Latin America Ocular Inflammation Treatment Market Size by Type
9.2.1 Latin America Ocular Inflammation Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Ocular Inflammation Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Ocular Inflammation Treatment Market Size by Type (2016-2027)
9.3 Latin America Ocular Inflammation Treatment Market Size by Application
9.3.1 Latin America Ocular Inflammation Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Ocular Inflammation Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Ocular Inflammation Treatment Market Size by Application (2016-2027)
9.4 Latin America Ocular Inflammation Treatment Market Size by Country
9.4.1 Latin America Ocular Inflammation Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Ocular Inflammation Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Ocular Inflammation Treatment Market Size (2016-2027)
10.2 Middle East & Africa Ocular Inflammation Treatment Market Size by Type
10.2.1 Middle East & Africa Ocular Inflammation Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ocular Inflammation Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ocular Inflammation Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Ocular Inflammation Treatment Market Size by Application
10.3.1 Middle East & Africa Ocular Inflammation Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ocular Inflammation Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ocular Inflammation Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Ocular Inflammation Treatment Market Size by Country
10.4.1 Middle East & Africa Ocular Inflammation Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ocular Inflammation Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan Plc.
11.1.1 Allergan Plc. Company Details
11.1.2 Allergan Plc. Business Overview
11.1.3 Allergan Plc. Ocular Inflammation Treatment Introduction
11.1.4 Allergan Plc. Revenue in Ocular Inflammation Treatment Business (2016-2021)
11.1.5 Allergan Plc. Recent Development
11.2 Cipla Ltd.
11.2.1 Cipla Ltd. Company Details
11.2.2 Cipla Ltd. Business Overview
11.2.3 Cipla Ltd. Ocular Inflammation Treatment Introduction
11.2.4 Cipla Ltd. Revenue in Ocular Inflammation Treatment Business (2016-2021)
11.2.5 Cipla Ltd. Recent Development
11.3 Pfizer, Inc.
11.3.1 Pfizer, Inc. Company Details
11.3.2 Pfizer, Inc. Business Overview
11.3.3 Pfizer, Inc. Ocular Inflammation Treatment Introduction
11.3.4 Pfizer, Inc. Revenue in Ocular Inflammation Treatment Business (2016-2021)
11.3.5 Pfizer, Inc. Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Ocular Inflammation Treatment Introduction
11.4.4 Novartis AG Revenue in Ocular Inflammation Treatment Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 Valeant Pharmaceuticals International, Inc.
11.5.1 Valeant Pharmaceuticals International, Inc. Company Details
11.5.2 Valeant Pharmaceuticals International, Inc. Business Overview
11.5.3 Valeant Pharmaceuticals International, Inc. Ocular Inflammation Treatment Introduction
11.5.4 Valeant Pharmaceuticals International, Inc. Revenue in Ocular Inflammation Treatment Business (2016-2021)
11.5.5 Valeant Pharmaceuticals International, Inc. Recent Development
11.6 Alimera Sciences, Inc.
11.6.1 Alimera Sciences, Inc. Company Details
11.6.2 Alimera Sciences, Inc. Business Overview
11.6.3 Alimera Sciences, Inc. Ocular Inflammation Treatment Introduction
11.6.4 Alimera Sciences, Inc. Revenue in Ocular Inflammation Treatment Business (2016-2021)
11.6.5 Alimera Sciences, Inc. Recent Development
11.7 Akorn, Inc.
11.7.1 Akorn, Inc. Company Details
11.7.2 Akorn, Inc. Business Overview
11.7.3 Akorn, Inc. Ocular Inflammation Treatment Introduction
11.7.4 Akorn, Inc. Revenue in Ocular Inflammation Treatment Business (2016-2021)
11.7.5 Akorn, Inc. Recent Development
11.8 Abbvie, Inc.
11.8.1 Abbvie, Inc. Company Details
11.8.2 Abbvie, Inc. Business Overview
11.8.3 Abbvie, Inc. Ocular Inflammation Treatment Introduction
11.8.4 Abbvie, Inc. Revenue in Ocular Inflammation Treatment Business (2016-2021)
11.8.5 Abbvie, Inc. Recent Development
11.9 Eyegate Pharmaceuticals, Inc.
11.9.1 Eyegate Pharmaceuticals, Inc. Company Details
11.9.2 Eyegate Pharmaceuticals, Inc. Business Overview
11.9.3 Eyegate Pharmaceuticals, Inc. Ocular Inflammation Treatment Introduction
11.9.4 Eyegate Pharmaceuticals, Inc. Revenue in Ocular Inflammation Treatment Business (2016-2021)
11.9.5 Eyegate Pharmaceuticals, Inc. Recent Development
11.10 pSivida Corporation
11.10.1 pSivida Corporation Company Details
11.10.2 pSivida Corporation Business Overview
11.10.3 pSivida Corporation Ocular Inflammation Treatment Introduction
11.10.4 pSivida Corporation Revenue in Ocular Inflammation Treatment Business (2016-2021)
11.10.5 pSivida Corporation Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Ocular Inflammation Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunosuppressant
Table 3. Key Players of Monoclonal Antibodies
Table 4. Key Players of Corticosteroids
Table 5. Key Players of Cycloplegic Agents
Table 6. Key Players of Antibiotics
Table 7. Key Players of Analgesics
Table 8. Key Players of Antivirals
Table 9. Key Players of Antifungal
Table 10. Global Ocular Inflammation Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Ocular Inflammation Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Ocular Inflammation Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Ocular Inflammation Treatment Market Share by Regions (2016-2021)
Table 14. Global Ocular Inflammation Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Ocular Inflammation Treatment Market Share by Regions (2022-2027)
Table 16. Ocular Inflammation Treatment Market Trends
Table 17. Ocular Inflammation Treatment Market Drivers
Table 18. Ocular Inflammation Treatment Market Challenges
Table 19. Ocular Inflammation Treatment Market Restraints
Table 20. Global Ocular Inflammation Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Ocular Inflammation Treatment Market Share by Players (2016-2021)
Table 22. Global Top Ocular Inflammation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ocular Inflammation Treatment as of 2020)
Table 23. Ranking of Global Top Ocular Inflammation Treatment Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Ocular Inflammation Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Ocular Inflammation Treatment Product Solution and Service
Table 27. Date of Enter into Ocular Inflammation Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Ocular Inflammation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Ocular Inflammation Treatment Revenue Market Share by Type (2016-2021)
Table 31. Global Ocular Inflammation Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Ocular Inflammation Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Ocular Inflammation Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Ocular Inflammation Treatment Revenue Market Share by Application (2016-2021)
Table 35. Global Ocular Inflammation Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Ocular Inflammation Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Ocular Inflammation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Ocular Inflammation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Ocular Inflammation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Ocular Inflammation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Ocular Inflammation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Ocular Inflammation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Ocular Inflammation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Ocular Inflammation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Ocular Inflammation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Ocular Inflammation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Ocular Inflammation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Ocular Inflammation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Ocular Inflammation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Ocular Inflammation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Ocular Inflammation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Ocular Inflammation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Ocular Inflammation Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Ocular Inflammation Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Ocular Inflammation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Ocular Inflammation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Ocular Inflammation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Ocular Inflammation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Ocular Inflammation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Ocular Inflammation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Ocular Inflammation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Ocular Inflammation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Ocular Inflammation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Ocular Inflammation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Ocular Inflammation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Ocular Inflammation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 67. Allergan Plc. Company Details
Table 68. Allergan Plc. Business Overview
Table 69. Allergan Plc. Ocular Inflammation Treatment Product
Table 70. Allergan Plc. Revenue in Ocular Inflammation Treatment Business (2016-2021) & (US$ Million)
Table 71. Allergan Plc. Recent Development
Table 72. Cipla Ltd. Company Details
Table 73. Cipla Ltd. Business Overview
Table 74. Cipla Ltd. Ocular Inflammation Treatment Product
Table 75. Cipla Ltd. Revenue in Ocular Inflammation Treatment Business (2016-2021) & (US$ Million)
Table 76. Cipla Ltd. Recent Development
Table 77. Pfizer, Inc. Company Details
Table 78. Pfizer, Inc. Business Overview
Table 79. Pfizer, Inc. Ocular Inflammation Treatment Product
Table 80. Pfizer, Inc. Revenue in Ocular Inflammation Treatment Business (2016-2021) & (US$ Million)
Table 81. Pfizer, Inc. Recent Development
Table 82. Novartis AG Company Details
Table 83. Novartis AG Business Overview
Table 84. Novartis AG Ocular Inflammation Treatment Product
Table 85. Novartis AG Revenue in Ocular Inflammation Treatment Business (2016-2021) & (US$ Million)
Table 86. Novartis AG Recent Development
Table 87. Valeant Pharmaceuticals International, Inc. Company Details
Table 88. Valeant Pharmaceuticals International, Inc. Business Overview
Table 89. Valeant Pharmaceuticals International, Inc. Ocular Inflammation Treatment Product
Table 90. Valeant Pharmaceuticals International, Inc. Revenue in Ocular Inflammation Treatment Business (2016-2021) & (US$ Million)
Table 91. Valeant Pharmaceuticals International, Inc. Recent Development
Table 92. Alimera Sciences, Inc. Company Details
Table 93. Alimera Sciences, Inc. Business Overview
Table 94. Alimera Sciences, Inc. Ocular Inflammation Treatment Product
Table 95. Alimera Sciences, Inc. Revenue in Ocular Inflammation Treatment Business (2016-2021) & (US$ Million)
Table 96. Alimera Sciences, Inc. Recent Development
Table 97. Akorn, Inc. Company Details
Table 98. Akorn, Inc. Business Overview
Table 99. Akorn, Inc. Ocular Inflammation Treatment Product
Table 100. Akorn, Inc. Revenue in Ocular Inflammation Treatment Business (2016-2021) & (US$ Million)
Table 101. Akorn, Inc. Recent Development
Table 102. Abbvie, Inc. Company Details
Table 103. Abbvie, Inc. Business Overview
Table 104. Abbvie, Inc. Revenue in Ocular Inflammation Treatment Business (2016-2021) & (US$ Million)
Table 105. Abbvie, Inc. Recent Development
Table 106. Eyegate Pharmaceuticals, Inc. Company Details
Table 107. Eyegate Pharmaceuticals, Inc. Business Overview
Table 108. Eyegate Pharmaceuticals, Inc. Ocular Inflammation Treatment Product
Table 109. Eyegate Pharmaceuticals, Inc. Revenue in Ocular Inflammation Treatment Business (2016-2021) & (US$ Million)
Table 110. Eyegate Pharmaceuticals, Inc. Recent Development
Table 111. pSivida Corporation Company Details
Table 112. pSivida Corporation Business Overview
Table 113. pSivida Corporation Ocular Inflammation Treatment Product
Table 114. pSivida Corporation Revenue in Ocular Inflammation Treatment Business (2016-2021) & (US$ Million)
Table 115. pSivida Corporation Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ocular Inflammation Treatment Market Share by Type: 2020 VS 2027
Figure 2. Immunosuppressant Features
Figure 3. Monoclonal Antibodies Features
Figure 4. Corticosteroids Features
Figure 5. Cycloplegic Agents Features
Figure 6. Antibiotics Features
Figure 7. Analgesics Features
Figure 8. Antivirals Features
Figure 9. Antifungal Features
Figure 10. Global Ocular Inflammation Treatment Market Share by Application: 2020 VS 2027
Figure 11. Retail Pharmacies Case Studies
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Online Pharmacies Case Studies
Figure 14. Drug Stores Case Studies
Figure 15. Ocular Inflammation Treatment Report Years Considered
Figure 16. Global Ocular Inflammation Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Ocular Inflammation Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Ocular Inflammation Treatment Market Share by Regions: 2020 VS 2027
Figure 19. Global Ocular Inflammation Treatment Market Share by Regions (2022-2027)
Figure 20. Global Ocular Inflammation Treatment Market Share by Players in 2020
Figure 21. Global Top Ocular Inflammation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ocular Inflammation Treatment as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Ocular Inflammation Treatment Revenue in 2020
Figure 23. Global Ocular Inflammation Treatment Revenue Market Share by Type (2016-2021)
Figure 24. Global Ocular Inflammation Treatment Revenue Market Share by Type (2022-2027)
Figure 25. North America Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Ocular Inflammation Treatment Market Share by Type (2016-2027)
Figure 27. North America Ocular Inflammation Treatment Market Share by Application (2016-2027)
Figure 28. North America Ocular Inflammation Treatment Market Share by Country (2016-2027)
Figure 29. United States Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Ocular Inflammation Treatment Market Share by Type (2016-2027)
Figure 33. Europe Ocular Inflammation Treatment Market Share by Application (2016-2027)
Figure 34. Europe Ocular Inflammation Treatment Market Share by Country (2016-2027)
Figure 35. Germany Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Ocular Inflammation Treatment Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Ocular Inflammation Treatment Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Ocular Inflammation Treatment Market Share by Region (2016-2027)
Figure 45. China Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Ocular Inflammation Treatment Market Share by Type (2016-2027)
Figure 53. Latin America Ocular Inflammation Treatment Market Share by Application (2016-2027)
Figure 54. Latin America Ocular Inflammation Treatment Market Share by Country (2016-2027)
Figure 55. Mexico Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Ocular Inflammation Treatment Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Ocular Inflammation Treatment Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Ocular Inflammation Treatment Market Share by Country (2016-2027)
Figure 61. Turkey Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Ocular Inflammation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Allergan Plc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2016-2021)
Figure 65. Cipla Ltd. Revenue Growth Rate in Ocular Inflammation Treatment Business (2016-2021)
Figure 66. Pfizer, Inc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2016-2021)
Figure 67. Novartis AG Revenue Growth Rate in Ocular Inflammation Treatment Business (2016-2021)
Figure 68. Valeant Pharmaceuticals International, Inc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2016-2021)
Figure 69. Alimera Sciences, Inc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2016-2021)
Figure 70. Akorn, Inc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2016-2021)
Figure 71. Abbvie, Inc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2016-2021)
Figure 72. Eyegate Pharmaceuticals, Inc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2016-2021)
Figure 73. pSivida Corporation Revenue Growth Rate in Ocular Inflammation Treatment Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

---